0000899243-23-015206.txt : 20230609
0000899243-23-015206.hdr.sgml : 20230609
20230609165626
ACCESSION NUMBER: 0000899243-23-015206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson David Michael
CENTRAL INDEX KEY: 0001808098
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 231006099
MAIL ADDRESS:
STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC
STREET 2: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0001501796
Aura Biosciences, Inc.
AURA
0001808098
Johnson David Michael
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
1
0
0
0
0
Stock Option (Right to Buy)
12.83
2023-06-07
4
A
0
16000
0.00
A
2033-06-07
Common Stock
16000
16000
D
This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 7, 2024 or (b) the next annual meeting of the Issuer's stockholders.
/s/ Julie Feder, Attorney-in-fact
2023-06-09